• 1. Optical fibre fluorosensor for cadmium with diethylaminoethyl-Sephadex as a substrate
  Jianzhong Lu,Zhujun Zhang Analyst 1995 120 453
• 2. Large-scale production of compound bubbles using parallelized microfluidics for efficient extraction of metal ions
  Heon-Ho Jeong,Zhuo Chen,Sagar Yadavali,Jianhong Xu,David Issadore,Daeyeon Lee Lab Chip 2019 19 665
• 3. Probing acid/base chemistry and adsorption mechanisms of hydrolysable Al(iii) species with a clay system in aqueous solution
  Yanfang Huang,Wencui Chai,Guihong Han,Jiongtian Liu,Hongyang Wu,Shengpeng Su,Yijun Cao RSC Adv. 2016 6 114171
• 4. Ratiometric optical oxygen sensing: a review in respect of material design
  Yan Feng,Jinghui Cheng,Li Zhou,Xiangge Zhou,Haifeng Xiang Analyst 2012 137 4885
• 5. A new approach towards simultaneous extraction of individual analytes based on the simultaneous application of multiple magnetic sorbents
  Mohammad Reza Fattahi Bafghi,Shayessteh Dadfarnia,Ali Mohammad Haji Shabani,Elahe Kazemi,Mahnaz Nozohour Yazdi J. Anal. At. Spectrom. 2020 35 2974

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroxyquinolines

Introduction to 8-Hydroxy-7-iodoquinoline-5-sulfonic acid (CAS No. 547-91-1)

8-Hydroxy-7-iodoquinoline-5-sulfonic acid (CAS No. 547-91-1) is a versatile compound with significant applications in the fields of medicinal chemistry, biochemistry, and pharmaceutical research. This compound, characterized by its unique molecular structure, has garnered attention for its potential therapeutic properties and its role in various biochemical processes. In this comprehensive introduction, we will delve into the chemical properties, biological activities, and recent research advancements associated with 8-Hydroxy-7-iodoquinoline-5-sulfonic acid.

The chemical structure of 8-Hydroxy-7-iodoquinoline-5-sulfonic acid is composed of a quinoline ring substituted with a hydroxyl group at the 8-position, an iodine atom at the 7-position, and a sulfonic acid group at the 5-position. This intricate arrangement imparts specific physicochemical properties to the molecule, making it suitable for various applications in scientific research and drug development.

In terms of physicochemical properties, 8-Hydroxy-7-iodoquinoline-5-sulfonic acid is a white crystalline solid with a molecular weight of approximately 360.04 g/mol. It is soluble in water and exhibits good stability under standard laboratory conditions. The presence of the sulfonic acid group enhances its solubility in aqueous solutions, which is advantageous for its use in biological assays and pharmaceutical formulations.

The biological activities of 8-Hydroxy-7-iodoquinoline-5-sulfonic acid have been extensively studied in recent years. One of the key areas of interest is its potential as an antimicrobial agent. Research has shown that this compound exhibits broad-spectrum antimicrobial activity against various bacterial strains, including both Gram-positive and Gram-negative bacteria. The mechanism of action is believed to involve the disruption of bacterial cell membranes and the inhibition of essential metabolic pathways.

Beyond its antimicrobial properties, 8-Hydroxy-7-iodoquinoline-5-sulfonic acid has also been investigated for its anti-inflammatory effects. Studies have demonstrated that it can inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6, which are involved in the pathogenesis of inflammatory diseases. This makes it a promising candidate for the development of new anti-inflammatory drugs.

In addition to its direct biological activities, 8-Hydroxy-7-iodoquinoline-5-sulfonic acid has been explored as a lead compound for drug discovery. Its unique structure provides a scaffold for the design and synthesis of novel derivatives with enhanced therapeutic properties. For instance, researchers have synthesized analogs with modified substituents on the quinoline ring to improve their pharmacological profiles and reduce potential side effects.

The use of 8-Hydroxy-7-iodoquinoline-5-sulfonic acid in combination therapies has also been a focus of recent studies. Combining this compound with other antimicrobial or anti-inflammatory agents has shown synergistic effects, leading to improved treatment outcomes. This approach is particularly relevant in addressing multidrug-resistant pathogens and chronic inflammatory conditions.

In the context of drug delivery systems, 8-Hydroxy-7-iodoquinoline-5-sulfonic acid has been incorporated into various formulations to enhance its bioavailability and target specificity. Nanoparticle-based delivery systems have shown promise in improving the pharmacokinetic properties of this compound, allowing for more effective and sustained release at the site of action.

The safety profile of 8-Hydroxy-7-iodoquinoline-5-sulfonic acid has been evaluated through preclinical studies. These studies have indicated that it is generally well-tolerated at therapeutic doses, with minimal toxicity observed in animal models. However, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.

In conclusion, 8-Hydroxy-7-iodoquinoline-5-sulfonic acid (CAS No. 547-91-1) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers specific physicochemical properties that make it suitable for various applications, including antimicrobial and anti-inflammatory therapies. Ongoing research continues to uncover new insights into its biological activities and therapeutic potential, paving the way for innovative drug development strategies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)